223 related articles for article (PubMed ID: 17407636)
1. A double-blind study evaluating the long-term safety of varenicline for smoking cessation.
Williams KE; Reeves KR; Billing CB; Pennington AM; Gong J
Curr Med Res Opin; 2007 Apr; 23(4):793-801. PubMed ID: 17407636
[TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.
Tsai ST; Cho HJ; Cheng HS; Kim CH; Hsueh KC; Billing CB; Williams KE
Clin Ther; 2007 Jun; 29(6):1027-39. PubMed ID: 17692719
[TBL] [Abstract][Full Text] [Related]
3. Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.
Bolliger CT; Issa JS; Posadas-Valay R; Safwat T; Abreu P; Correia EA; Park PW; Chopra P
Clin Ther; 2011 Apr; 33(4):465-77. PubMed ID: 21635992
[TBL] [Abstract][Full Text] [Related]
4. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
Tonstad S
J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers.
Nakamura M; Oshima A; Fujimoto Y; Maruyama N; Ishibashi T; Reeves KR
Clin Ther; 2007 Jun; 29(6):1040-56. PubMed ID: 17692720
[TBL] [Abstract][Full Text] [Related]
6. Varenicline: a first-line treatment option for smoking cessation.
Garrison GD; Dugan SE
Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial.
Hoogsteder PH; Kotz D; van Spiegel PI; Viechtbauer W; Brauer R; Kessler PD; Kalnik MW; Fahim RE; van Schayck OC
BMC Public Health; 2012 Dec; 12():1052. PubMed ID: 23216646
[TBL] [Abstract][Full Text] [Related]
8. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
[TBL] [Abstract][Full Text] [Related]
9. Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study.
Cui Q; Robinson L; Elston D; Smaill F; Cohen J; Quan C; McFarland N; Thabane L; McIvor A; Zeidler J; Smieja M
AIDS Patient Care STDS; 2012 Jan; 26(1):12-9. PubMed ID: 22007690
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Faessel H; Ravva P; Williams K
Clin Ther; 2009 Jan; 31(1):177-89. PubMed ID: 19243716
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM
JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial.
Niaura R; Hays JT; Jorenby DE; Leone FT; Pappas JE; Reeves KR; Williams KE; Billing CB
Curr Med Res Opin; 2008 Jul; 24(7):1931-41. PubMed ID: 18513462
[TBL] [Abstract][Full Text] [Related]
13. Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial.
Tashkin DP; Rennard S; Hays JT; Ma W; Lawrence D; Lee TC
Chest; 2011 Mar; 139(3):591-599. PubMed ID: 20864613
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
[TBL] [Abstract][Full Text] [Related]
15. Varenicline to stop long-term nicotine replacement use: a double-blind, randomized, placebo-controlled trial.
Tønnesen P; Mikkelsen K
Nicotine Tob Res; 2013 Feb; 15(2):419-27. PubMed ID: 23024246
[TBL] [Abstract][Full Text] [Related]
16. Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study.
Chengappa KN; Perkins KA; Brar JS; Schlicht PJ; Turkin SR; Hetrick ML; Levine MD; George TP
J Clin Psychiatry; 2014 Jul; 75(7):765-72. PubMed ID: 25006684
[TBL] [Abstract][Full Text] [Related]
17. Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries.
Fagerström K; Nakamura M; Cho HJ; Tsai ST; Wang C; Davies S; Ma W; Lee TC; Russ C
Curr Med Res Opin; 2010 Sep; 26(9):2165-73. PubMed ID: 20666691
[TBL] [Abstract][Full Text] [Related]
18. A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial.
Wong J; Abrishami A; Yang Y; Zaki A; Friedman Z; Selby P; Chapman KR; Chung F
Anesthesiology; 2012 Oct; 117(4):755-64. PubMed ID: 22890119
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
Williams JM; Anthenelli RM; Morris CD; Treadow J; Thompson JR; Yunis C; George TP
J Clin Psychiatry; 2012 May; 73(5):654-60. PubMed ID: 22697191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]